Skip to main content
. 2014 Sep 15;14:671. doi: 10.1186/1471-2407-14-671

Table 1.

Study visits and procedures

At inclusion 3-monthly At PSA or symptomatic progression
Eligibility check *
Informed consent *
PET-CT * *
QOL questionnaire * * *
Toxicity assessment * * *
PSA measurement * * *
History and physical examination * * *

*reflects the timepoint of a certain assessment.